Company Overview of Pericor Science Incorporated
Pericor Science Incorporated, a development stage biopharmaceutical company, develops therapeutics by using the TransLink System to enhance existing drugs or therapeutic molecules. Its lead compound, PTI 101, is a TransLink direct thrombin inhibitor for thrombosis and stenosis. The company was founded in 1999 and is based in Boston, Massachusetts.
50 Rowes Wharf
Boston, MA 02110
Founded in 1999
Key Executives for Pericor Science Incorporated
Similar Private Companies By Industry
|Noble Molecules, Inc.||United States|
|CerRx Inc.||United States|
|Bio-multimin, Inc.||United States|
|Renaissance Acquisition Holdings, LLC||United States|
|Plantaceutica, Inc||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Pericor Science Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.